BioMarin Pharma (BMRN) Posts Q3 GAAP Loss of 38c/Share

October 24, 2013 5:05 PM

BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) reported Q3 EPS of ($0.38), $0.08 worse than the analyst estimate of ($0.30). Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found